Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice

Cancer Research

Volumn 56, Issue 5, 1996, Pages 1098-1103

  Arteaga, Carlos L ^a,b   Holt, Jeffrey T ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL SURVIVAL; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GROWTH INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE C FOS; PRIORITY JOURNAL; PROTO ONCOGENE; RETROVIRUS; TISSUE SPECIFICITY; TUMOR GROWTH; XENOGRAFT;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; RETROVIRIDAE; RNA, ANTISENSE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030045221     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lippman, M. E., and Dickson, R B. Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog Horm. Res., 45: 383-440, 1989.
2. Dubik, D., Dembinski, T. C , and Shiu, R. P. C. Stimulation of c-myc oncogene expression associates with estrogen-induced proliferation of human breast cancer cells. Cancer Res., 47, 6517-6521, 1987.
3. Dubik, D., and Shiu, R. P. C. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF-7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol Chem , 268, 14103-14108, 1993
4. Loose-Mitchell, D. S, Chiappetta, C , and Stancel, G. M. Estrogen regulation of c-fos messenger ribonucleic acid Mol. Endocrinol., 2: 946-951, 1988.
5. Aiken, S C , and Lippman, M. E. Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. Cancer Res., 45: 1611-1620, 1985
6. Arteaga, C. L., Coronado, E. B , and Osborne, C. K. Blockade of the epidermal growth factor receptor inhibits transforming growth factor α-induced but not estrogen-induced growth of hormone-dependent human breast cancer Mol Endocrinol., 2: 1064-1069, 1988
7. Arteaga, C L., Hurd, S. D , Winnier, A. R , Johnson, M. D , Fendly, M D., and Forbes, J T. AntiTGFβ antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: implications for a possible role of tumor cell/host TGFβ interactions in human breast cancer progression. J. Clin. Invest , 92: 2569-2576, 1993
8. Osborne, C. K., Coronado, E. B , Arteaga, C. L , Kitten, L. J., Fuqua, S. A. W., Ramasharma, K., Marshall, M., and Li, C. H. Insulin-like growth factor II (IGF-II), a potential autocrine/paracrine factor for human breast cancer acting via the IGF-1 receptor. Mol Endocrinol , 3: 1701-1709, 1989
9. Gaub, M. P., Bellard, M , Scheuer, I , Chambon, P , and Sassone-Corsi, P Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex Cell, 63, 1267-1276, 1990
10. Diamond, M. I, Miner, J. N., Yoshinaga, S. K., and Yamamoto, K M Transcription factor interactions: selectors of positive or negative regulation from a single DNA element Science (Washington DC), 249: 1266-1272, 1990.
11. Jonat, C. G., Rahmsdorf, H. J., Park, K K., Cato, A. C. B., Ponta, H., and Herrlich, P Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos-Jun) activity by glucocorticoid hormone Cell, 62: 1189-1204, 1990
12. Yang-Yen, H. F., Chambard, J C., Sun, Y. L., Smeal, T., Schmidt, T. J., Drouin, J., Karin, M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell, 62: 1205-1215, 1990
13. Holt, J T , Gopal, T V., Moulton, A. D , and Nienhuis, A. W. Inducible production of c-fos anti-sense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA, 83: 4794-4798, 1986.
14. Kerr, L. D., Holt, J. T , and Matrisian, L. M Growth factors regulate transin gene expression by c-fos dependent and c-fos independent pathways Science (Washington DC), 242: 1424-1427, 1988.
15. Schonthal, A., Herrlich, P., Rahmsdorf, H., and Ponta, H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell, 54: 325-334, 1988.
16. Kim, S-J., Denhez, F., Kim, K-Y., Holt, J. T., Sporn, M. B., Roberts, A. B. Activation of the second promoter of the TGF-β1 gene by TGF-β1 and phorbol ester occurs through the same target sequences. J. Biol Chem., 264: 19373-19378, 1989.
17. Jensen, R. A., Page, D. L., and Holt, J. T. Identification of genes expressed in premalignant breast disease by microscopy-directed cloning. Proc. Natl Acad. Sci. USA, 91: 9237-9261, 1994.
18. Thompson, M E., Jensen, R. A., Obermiller, P. S , Page, D L , and Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet., 9: 444-450, 1995
19. Cato, A. C., Weinmann, J., Mink, S , Ponta, H., Henderson, D., and Sonnenberg, A. The regulation of expression of mouse mammary tumor virus DNA by steroid hormones and growth factors. J. Steroid Biochem., 34: 139-144, 1989
20. Choi, Y , Henrard, D., Lee, I., and Ross, S. R. The mouse mammary tumor virus long terminal repeat directs expression in epithelial and lymphoid cells of different tissues in transgenic mice J Virol., 61: 3013-3030, 1987.
21. Matsui, Y., Halter, S. A., Holt, J T., Hogan, B L. M. and Coffey, R. J., Jr. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell. 61: 1147-1155, 1990.
22. Halter, S. A., Dempsey, P. J., Matsui, Y., Stokes, M. K., Graves-Deal, R., Hogan, B. L M., and Coffey R. J. Distinctive patterns of hyperplasia in MMTV-TGFα transgenic mice: characterization of mammary gland and skin proliferations. Am. J. Pathol., 140: 1131-1146, 1992.
23. Arteaga, C. L., Kitten, L., Coronado, E B , Jacobs, S., Kull, F., Alred, C., and Osborne, C. K. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J. Clin Invest., 84, 1418-1423, 1989
24. Welsh, R. M., Jensen, F C , Cooper, N. R., and Oldstone, M B. A. Human serum lyses RNA tumor viruses. Nature (Lond), 257: 612-615, 1975.
25. Cooper, N. R., Jensen, F. C., Welsh, R M., and Oldstone, M B. A. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J. Exp. Med , 144: 970-984, 1976.
26. Muller, W. J., Sinn, E , Pattengale, P. K., Wallace, R., and Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54: 105-115, 1988
27. Weisz, A., and Resales, R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res., 18: 5097-5106, 1990.
28. Hyder, S. M., Nawaz, Z , Chiappetta, C , Yokoyama, K., and Stancel, G. M. The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence J Biol. Chem., 270: 8506-8513, 1995
29. Pittelkow, M R Lindquist, P B , Derynek, R., Abraham, R. T , Graves-Deal, R , and Coffey, R. J. Induction of transforming growth factor-α expression in human keratinocytes by phorbol esters J. Biol. Chem., 264: 5164-5171, 1989.
30. Kenney, N. J., Seaki, T , Gottardis, M., Kim, N., Garcia-Morales, P., Martin, M. B., Normanno, N., Ciardello, F., Day, A., and Cutler M. L. Expression of transforming growth factor α antisense mRNA inhibits the estrogen-induced production of TGFα and estrogen-induced proliferation of human breast cancer cells J. Cell. Physiol., 156: 497-514, 1993.
31. Reddy, K. B , Yee, D., Hilsenbeck, S. G., Coffey, R. J , and Osborne, C. K. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor α expression. Cell Growth & Differ., 5: 1275-1282, 1994.
32. Arteaga, C L., Carty-Duger, Y , Moses, H. L., Hard, S. D., and Pietenpol, J. A. Transforming growth factor-β1 can induce estrogen-independent tumorigenicity of human breast carcinoma cells in vivo Cell Growth & Differ., 4: 193-201, 1993
33. Hennigan, R. F., Hawker, K L., and Ozanne, B W. Fos-transformation activates genes associated with invasion. Oncogene, 9 3591-3600, 1994